Legal Name: ENDURANT CAPITAL MANAGEMENT LP
報告期間:
Jun 30, 2019
有効日:
Aug 14, 2019
セキュリティ |
保有株式/元本 |
市場価格 |
オプション |
TAKEDA PHARMACEUTICAL CO LTD (874060205)
|
932,967 |
$16,514k |
|
LABORATORY CORP AMER (50540R409)
|
82,900 |
$14,333k |
|
ZIMMER BIOMET HLDGS (98956P102)
|
109,632 |
$12,908k |
|
WRIGHT MEDICAL GROUP NV (NE) (N96617118)
|
371,979 |
$11,092k |
|
R1 RCM INC COM (749397105)
|
830,809 |
$10,452k |
|
CIGNA CORP (125523100)
|
61,590 |
$9,704k |
|
PRA Health Science (69354m108)
|
97,200 |
$9,637k |
|
INTRICON CORP COM (46121H109)
|
389,795 |
$9,106k |
|
OXFORD IMMUNOTEC GLOBAL PLC (G6855A103)
|
629,236 |
$8,658k |
|
FLUIDIGM CORP DEL (34385PAA6)
|
8,756,000 |
$8,386k |
|
IRHYTHM TECHNOLOGIES INC COM (450056106)
|
103,448 |
$8,181k |
|
SIENTRA INC (82621J105)
|
1,285,855 |
$7,921k |
|
HUMANA INC (444859102)
|
27,797 |
$7,375k |
|
Encompass Health Corp (29261A100)
|
114,801 |
$7,274k |
|
AVEDRO INC COM (05355N109)
|
357,942 |
$7,030k |
|
ATRICURE INC (04963C209)
|
219,038 |
$6,536k |
|
VOCERA COMMUNICATIONS INC (92857F107)
|
203,000 |
$6,480k |
|
ABBVIE INC (00287Y109)
|
89,008 |
$6,473k |
|
ABC (03073E105)
|
73,503 |
$6,267k |
|
Intersect ENT Inc. (46071F103)
|
270,561 |
$6,158k |
|
HCA HEALTHCARE (40412C101)
|
43,623 |
$5,897k |
|
SANOFI (80105N105)
|
120,614 |
$5,219k |
|
ASTRAZENECA (046353108)
|
124,859 |
$5,154k |
|
EVOLENT HEALTH INC 2 12/01/2021 (30050BAB7)
|
5,596,000 |
$4,974k |
|
DENTSPLY SIRONA INC (24906P109)
|
82,813 |
$4,833k |
|
Iovance Biotherapeutics Inc (462260100)
|
173,238 |
$4,248k |
|
NEVRO CORP COM (64157F103)
|
63,394 |
$4,110k |
|
Bristol-Myers Squibb Co (110122108)
|
86,297 |
$3,914k |
|
LIQUIDIA TECHNOLOGIES INC (53635D202)
|
468,981 |
$3,752k |
|
ACLARIS THERAPEUTICS INC (00461U105)
|
1,629,327 |
$3,568k |
|
GW PHARMACEUTICALS PLC ADS (36197T103)
|
18,210 |
$3,139k |
|
INTEGRA LIFESCIENCES HLDGS (457985208)
|
42,827 |
$2,392k |
|
Surgery Partners Inc (86881A100)
|
287,720 |
$2,342k |
|
NEON THERAPEUTICS INC (64050Y100)
|
465,650 |
$2,207k |
|
OSMOTICA PHARMACEUTICALS PLC (G6S41R101)
|
514,239 |
$1,954k |
|
DAVITA INC (23918K108)
|
32,566 |
$1,832k |
|
GRITSTONE ONCOLOGY INC (39868T105)
|
143,752 |
$1,601k |
|
SENSEONICS HLDGS INC (81727UAA3)
|
1,500,000 |
$1,540k |
|
MARINUS PHARMACEUTICALS INC CO (56854Q101)
|
362,189 |
$1,503k |
|
SI BONE INC COM (825704109)
|
65,216 |
$1,326k |
|
TANDEM DIABETES CARE (875372203)
|
19,579 |
$1,263k |
|
BIO RAD LABS INC (090572207)
|
3,735 |
$1,168k |
|
GENOCEA BIOSCIENCES INC (372427401)
|
289,714 |
$1,136k |
|
MEDNAX Inc (58502B106)
|
39,401 |
$994k |
|
ACTINIUM PHARMACEUTICALS INC (00507W107)
|
2,481,355 |
$610k |
|
Sarepta Therapeutics Inc (803607100)
|
3,753 |
$570k |
|
ALIGN TECHNOLOGY INC (016255101)
|
1,962 |
$537k |
|
GLYCOMIMETICS INC (38000Q102)
|
42,271 |
$504k |
|
TRANSLATE BIO INC (89374L104)
|
38,772 |
$490k |
|
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
31,869 |
$379k |
|